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                Dean’s Newsletter
School of Medicine
UConn Creates  
Two New Stem Cell Lines
$4 Million Grant 
Studies Exercise as Aid to Quitting Smoking
Cheryl Oncken, M.D., associate professor of medicine, has received a five-year, $4 million federal grant to study whether exercise can help older women quit smoking and improve their overall health. 
 “Our goal is to study whether an exercise program can help postmenopausal women quit 
smoking and abstain from cigarettes,” says Oncken, a nationally recognized expert on smoking 
cessation, who received the grant from the National Institute on Drug Abuse.  
 “Most smoking research focuses on healthy women. Our study is looking at post- 
menopausal women who have greater risk of lower bone density, depression and 
weight gain than younger women,” says Oncken. 
 About 30 percent of female smokers are postmenopausal, and the proportion is 
expected to grow as the population ages. Smokers generally know about the harmful 
effects of smoking and want to stop, but most people have a hard time quitting. “It 
takes an average of three to five quit attempts to finally kick the habit,” says Oncken, 
who has studied the use of various medications and behavioral therapies designed to 
help people abstain. “Our goal is to find the most effective treatment or combination of 
treatments to help people achieve their goal.” 
 The study will recruit about 300 postmenopausal women, all of whom will receive 
behavioral counseling and the medication varenicline, and then be randomly assigned to either a 
supervised exercise program or a supervised relaxation control program.  
 “We hypothesize that women in the exercise program will have greater abstinence rates at the 
end of treatment and at the end of a year than women in the relaxation program,” says Oncken.  
The researchers also hypothesize that the ameliorative effects of exercise on smoking cessation 
and depression will improve abstinence rates among women with a history of depression equal 
to those with no history of depression, and that exercise will improve smoking cessation by 
reducing nicotine craving and by increasing self-confidence. n




Arthur Günzl, Ph.D., associate professor in the Department of Genetics and Developmental Biology, is the first Health Center 
researcher to be awarded a grant by the Bill and Melinda Gates 
Foundation. Günzl is one of 81 researchers around the world 
to receive a grant of $100,000 each through the foundation’s 
Grand Challenges Explorations initiative, which aims to 
develop a pipeline of creative ideas that could change the face 
of global health. The projects focus on novel approaches to 
prevent and treat infectious diseases, such as HIV, malaria, 
tuberculosis, pneumonia, and diarrheal diseases.  
 Günzl’s research focuses on Trypanosoma brucei, the 
parasite carried by the tsetse fly in Sub-Saharan Africa that 
causes sleeping sickness. There are an estimated 500,000 
cases each year, and in some African provinces, half of the 
population is infected. Untreated, the disease is invariably 
fatal. However, existing drugs are very toxic, too expensive, 
difficult to administer, and/or not effective against all subspecies 
W elcome to the first issue of our new publication. Designed to be a quick 
and easy read, our goal is to 
convey the energy and passion 
found throughout the dynamic 
University of Connecticut 
School of Medicine. 
 I became the seventh dean of 
the UConn School of Medicine 
and vice president for Health 
Affairs at the UConn Health 
Center just a year ago. I joined 
the UConn community from 
the University of Virginia, 
where I served as the Lillian T. 
American Cancer Society 
Supports Taylor’s  
Bladder Cancer Research
John Taylor, III, M.D., a urologist, researcher and assistant professor of surgery at the 
UConn School of Medicine, has 
received a five-year, $729,000 
research grant from the American 
Cancer Society for his study of the 
role of inflammatory molecules on 
the development and progression  
of bladder cancer.  
 “We currently have no markers 
to determine which patients with  
bladder cancer will have progression, 
which patients would benefit from  
early aggressive treatment, or 
even which patients will respond 
favorably to treatment,” Taylor says. 
“Our early data are quite promising 
and could lead to novel ways to 
manage this disease.”  
 The grant is one of 27 research 
projects the American Cancer 
Society is funding in Connecticut, 
totaling nearly $10 million. 
 “Virtually every major 
development in cancer research in 
the last half century can point to 
a Society-funded researcher who 
played a key role along the way, 
with most of those investigators 
getting Society support early in 
their careers when funding 
is particularly difficult 




president of health 
initiatives. 
 In 2005, 
Taylor was one of 
10 researchers in 
the country to receive 
a Dennis W. Jahnigen Scholars 
Award from the American Geriatrics 
Society. The two-year, $200,000 
grant helped fund his work on age-
related changes in the bladder. n
 
Pratt Distinguished Professor 
and chair of the Department of 
Orthopaedic Surgery.  
 Since my arrival, I have 
been continually impressed 
with the quality and intellectual 
vigor of our medical school 
faculty, students and alumni. 
Three times a year, these pages 
will highlight just some of the 
extraordinary accomplishments 
and talents of these people.  
We will share their stories and 
describe the impact they are 
having both here in Connecticut 
and well beyond. 
As you will see, I am 
unabashedly proud of this 
medical school and the entire 
UConn Health Center. Please 
spend a few minutes with the 




Cato T. Laurencin, M.D., Ph.D. 
Vice President for Health Affairs 
Dean, School of Medicine 
 
P.S.  I would enjoy hearing from you.   
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Dr. Cheryl Oncken is studying the 
connection between exercise and 
smoking cessation.
of the parasite. Moreover, resistance to existing drugs is on 
the rise and vaccine development is not in sight. Thus, new 
strategies to combat the parasite are urgently needed. 
 In light of the Gates Foundation grant, Günzl will be 
able to concentrate on a unique trait of T. brucei. The 
parasite lives freely in the human bloodstream and it 
must continuously swim forward to evade immune 
responses. Günzl will attempt to develop serum-
stable adhesive RNA molecules which immobilize 
trypanosomes on human endothelial cells. 
 “It’s just an idea, I have no preliminary data,” says 
Günzl. “From my previous research experience, I can see 
where it may work but I can also think of reasons why it 
might not work. But it is definitely worth trying.” 
 Günzl’s proposal to the Gates Foundation was only two 
pages long, which differs greatly from the lengthy and data-
proven proposals researchers need to submit to the National 
Institutes of Health in order to receive grant money. “It’s 
a nice thing for a scientist,” explains Günzl. “This grant is 
allowing me to go and do something completely new and 
unconventional, and that’s what can lead to big discoveries.” 
For instance, if Günzl’s hunch proves true, it could lead to a 
shortcut for a new treatment. The other funded researchers 
will explore a wide range of new ideas, including giving 
mosquitoes a “head cold” to prevent them from detecting and 
biting humans; developing a tomato to deliver antiviral drugs; 
and using a laser to enhance the effect of vaccines. Projects 
that show promise are eligible for additional funding of  
$1 million or more. n
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Grants
By creating and establishing the 
two new human embryonic stem 
cell lines, UConn joins an elite 
group of universities engaged in 
efforts to create, characterize and 
distribute new human embryonic 
stem cell lines for research and 
therapeutic purposes.
UConn School of Medicine scientists recently made two new lines of human embryonic stem cells available to academic researchers, joining an elite group of universities engaged in efforts to create, characterize and distribute new human embryonic stem cell lines for research and 
therapeutic purposes.
 “Distribution of these new lines helps broaden the state’s growing stem cell research community, 
and creates an additional supply of stem cells for research here and around the world,” says Ren-
He Xu, M.D., Ph.D., associate professor in the Department of Genetics and Developmental Biology 
at the medical school, and director of the university’s Stem Cell Core Laboratory. The two new lines – 
identified as CT1 and CT2 – were created last summer by Xu and Ge Lin, Ph.D., his colleague in  
the core lab. 
   The university’s core facility was established in 2007 after the Connecticut legislature and 
Gov. M. Jodi Rell set aside $100 million for embryonic and adult stem cell training and research 
programs at state universities. UConn’s core lab is culturing, testing and banking both federally 
approved and unapproved stem cell lines.  
 Because of the tendency for chromosomal abnormalities to increase with the cells’ age, or higher 
passages, Xu’s team applied DNA sequencing technology to obtain a detailed analysis of the molecular 
Two New Stem Cell Lines
signature of each cell line. “This established a genetic database for 
our cell lines against which researchers can compare their work. It 
helps them make sure any results they find are reliable,” says Xu. 
 Because the new Connecticut stem cell lines lack the genetic 
mutations and chromosomal abnormalities that often occur and 
accumulate in cell lines cultured and stored for a long time, they 
are highly prized by researchers. And because the cells are stored 
to await distribution after fewer than 15 passages – each passage 
is about one week’s growth of the embryonic stem cell colonies 
in vitro – they have greater research value. “Many scientists 
seeking to understand how embryonic stem cells differentiate 
need lines with low passage to guarantee a longer window 
of opportunity to manipulate the cells. Because our lines are 
younger, the scientists can work with them longer,” says Xu. 
 The two new Connecticut cell lines were derived from unused 
embryos donated for research with informed, written consent by 
patients of UConn’s Center for Advanced Reproductive Services. 
The work also was reviewed and approved by the university’s 
Embryonic Stem Cell Research Oversight Committee, a panel 
that oversees work with human stem cells.
 Besides creating the new lines, Xu and his team have been 
very involved in training other researchers in the culture 
Understanding the Immune Response
Using laser scanning microscopy, Health Center researchers have examined the cell dynamics of an immune response. By examining the spleens of mice infected with bacteria at different times during the infection, the researchers learned that the immune response appeared to 
begin in the lymphocyte-containing white pulp. A few days after the beginning of the immune 
response, the T cells moved between the white pulp and the red blood cell rich red pulp areas 
of the spleen through structures called “bridging channels.” 
 “Our study was designed to increase our understanding of the precise anatomical movement 
of cells responding to a real infection,” says Leo Lefrançois, Ph.D., professor of immunology, 
and one of the researchers involved in the study with graduate student Jeffrey McNamara 
and Kamal Khanna, Ph.D., a Damon-Runyon fellow. “The study revealed for the first time the 
anatomy of an ongoing immune response, information that could ultimately be used to help 
develop better therapies for fighting infection or blocking the response in autoimmune disorders,” 
says Lefrançois. Their research was published in a recent issue of Science. n 
and use of human embryonic stem cells. “We have held 15 
training classes and trained 100 scientists from UConn, 
Wesleyan University, Yale University and the University of 
Massachusetts.” In addition, UConn researchers are working 
on more than 20 different projects designed to promote 
understanding of the differentiation of stem cells and harness 
their therapeutic potential.
 “We are extremely fortunate to have a network of 
investigators with expertise in human embryonic stem cell 
culture methods, cell characterization methods and a core cell 
production facility adjacent to clinician scientists working to 
introduce stem cell therapies in medical practice,” says Marc 
Lalande, Ph.D., senior associate dean for research planning and 
coordination, professor and chair of the Department of Genetics 
and Development Biology, and director of the university’s Stem 
Cell Institute. “It is a unique collaboration that will help bring 
the potential benefits of this research to fruition.” n
w     Fall 2009UConn School of Medicine
Dr. Ge Lin working on new  
stem cell lines he created.
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In June of 2005, Connecticut became only 
the third state in the country to use its own 
money to fund human embryonic stem cell 
research. That pivotal decision helped to 
keep Connecticut in the forefront of stem 
cell research.
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Two Recent Honors: Laurencin Recognized for 
Contributions to Biomedical and Tissue Engineering, 
Receives Presidential Award for Mentoring
Cato T. Laurencin, M.D., Ph.D., vice president for health affairs and dean of the medical school, recently received two prestigious honors related to bioengineering and 
mentoring aspiring researchers.  
 In February, Laurencin was named the 2009 winner 
of the Pierre Galletti Award, the highest honor bestowed 
annually by the American Institute for Medical and Biological 
Engineering. He was recognized for “seminal contributions to 
tissue engineering and leadership in international biomedical 
engineering.” Established in 1999, the award is presented 
to an individual in recognition of his or her contributions to 
public awareness of medical and biological engineering, and  
to promotion of the national interest in science, engineering 
and education.  
 In July, Laurencin was among a select group of science, 
math and engineering educators named by President Barack 
Obama to receive the Presidential Award for Excellence. Each 
year, this award recognizes the crucial role that mentoring 
plays in the academic and personal development of students 
studying science or engineering. 
 “There is no higher calling than furthering the educational 
advancement of our nation’s young people and encouraging 
and inspiring our next generation of leaders,” President 
Obama said in a White House statement.  
 Throughout his career, Laurencin has earned national  
and international prominence as an orthopaedic surgeon  
and chemical engineering expert. He holds the Health Center’s 
Van Dusen Endowed Chair in Academic Medicine and is a 
professor in the Department of Orthopaedic Surgery. He also 
holds an appointment in the UConn School of Engineering 
as a professor of chemical, materials and biomolecular 
engineering. He is a fellow of the American Surgical 
Association and the American Academy of Orthopaedic 
Surgeons and was named one of the 100 engineers of the 
modern era by the American Institute of Chemical Engineers. 
 Laurencin joined UConn in 2008 from the University 
of Virginia where he was the Lillian T. Pratt Distinguished 
Professor and chair of the Department of Orthopaedic  
Surgery, the orthopaedic surgeon-in-chief at the University  
of Virginia Health System and a university professor, one  
of the university’s most prestigious titles. n 
Physician-Researcher Honored 
Zihai Li, M.D., Ph.D., a prominent physician-researcher and leader in the field of immunotherapy, was 
recently inducted into the American 
Society for Clinical Investigation, one of 
the nation’s oldest and most respected 
medical honor societies. 
 Li’s research team has made seminal 
contributions to understanding the 
immunological properties of heat shock proteins (HSPs) in 
cancer immunotherapy and immune tolerance. His work has 
broad implications in understanding how the immune system 
operates physiologically and how it might be harnessed for the 
prevention and treatment of human diseases. n
Kastner 
Receives AMA Leadership Award
Theodore A. Kastner, ’81, M.D., M.S., founder and president of Developmental Disabilities Health Alliance (DDHA), a New Jersey health care organization exclusively 
for individuals with developmental disabilities, has been 
named a recipient of the American Medical Association’s 2008 
Leadership Award. 
 Kastner was among 56 individuals nationwide honored 
by the AMA Foundation at its annual Excellence in Medicine 
Awards ceremony. Recipients of the award are recognized for 
demonstrating outstanding non-clinical leadership skills in 
advocacy, community service and education. 
 Throughout his career, Kastner has focused on a chronically 
underserved population: people with developmental 
disabilities. DDHA began as a single office in 1997 serving 200 
patients; today, it has six offices across New Jersey providing 
comprehensive health care services to more than 3,000 patients 
and health care management to 3,400 patients. n
Honors
Improving Access to Colonoscopies
Earlier this year, a statewide effort led by the UConn Health Center’s Colon Cancer Prevention Program made colonoscopies available to uninsured and underinsured Connecticut residents. The initiative provided colonoscopies to nearly 300 patients at no 
cost to them, nearly 50 of them done by Joseph C. Anderson, M.D., at the UConn Health Center. 
 “The colonoscopy is a major prevention tool, but not everyone has access,” says Anderson, 
the clinical director of the colon cancer prevention program and medical director for the 
Connecticut project. “The more people we can screen, the more people we can help. Polyps in 
the colon will become cancerous whether people have insurance or not.” 
 Unfortunately for those without insurance, the cost of the test, which can detect early signs 
of cancer, generally places it out of their reach.  
 Using a grant of $950,000 from the state Department of Public Health, the Health Center 
formed a partnership with federally funded community health centers and endoscopists 
around the state to identify patients between the ages of 50 and 65 and provide them with 
colonoscopies. The program provided follow-up services to participants. 
 “The goal is to promote, improve and optimize the appropriate use of high quality  
colorectal cancer screening and follow-up services, and eliminate or decrease racial, ethnic  
and socioeconomic disparities in access to these screenings,” says Jennifer Granger, chief 
operating officer of the Community Health Center Association of Connecticut.  
 Colon cancer is the second most common cancer and the third leading cause of cancer 
deaths in the nation. n
A$3.8 million gift from Carole and Ray Neag, two of the university’s 
most generous supporters, will 
help the Health Center upgrade 
its diagnostic, planning and 
treatment services.  
 The first installment, a new 
computerized tomography (CT) 
scanner offering unprecedented 
precision, speed and patient 
comfort, arrived this spring.  
The new scanner uses “dual-
source energy” technology, in 
which two sources of radiation 
are used to acquire information 
and create a complex 3D image 
of a patient’s anatomy. The 
technology gives physicians and 
researchers sophisticated images 
not previously available. 
 The Neags’ gift also provides 
for a high-dose radiation system 
and a CT simulator which, 
together with the scanner and the 
TomoTherapy cancer treatment 
system (provided by a previous 
gift from the Neags), greatly 
enhances research, education and 
treatment at the Health Center. 
 “Its functionality for 
cardiology alone will be leaps 
and bounds beyond our existing 
capabilities,” says Bruce Liang, 
M.D., director of the Pat and Jim 
Calhoun Cardiology Center.  
 Advantages of the new 
scanner include clearer images, a 
90 percent reduction in scanning 
times and selective presentation 
of a scanned image. The CT 
simulator will enhance treatment 
planning, and the high dose 
rate brachytherapy will treat a 
variety of cancers at the Neag 
Comprehensive Cancer Center.  
 “Carole and I feel strongly 
about the state and its university, 
and believe the state’s flagship 
research university should have 
the very best if at all possible,” 
says Ray Neag. n
Neag Gift Supports Imaging, 
Treatment Upgrades
6
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mentoring aspiring researchers.  
 In February, Laurencin was named the 2009 winner 
of the Pierre Galletti Award, the highest honor bestowed 
annually by the American Institute for Medical and Biological 
Engineering. He was recognized for “seminal contributions to 
tissue engineering and leadership in international biomedical 
engineering.” Established in 1999, the award is presented 
to an individual in recognition of his or her contributions to 
public awareness of medical and biological engineering, and  
to promotion of the national interest in science, engineering 
and education.  
 In July, Laurencin was among a select group of science, 
math and engineering educators named by President Barack 
Obama to receive the Presidential Award for Excellence. Each 
year, this award recognizes the crucial role that mentoring 
plays in the academic and personal development of students 
studying science or engineering. 
 “There is no higher calling than furthering the educational 
advancement of our nation’s young people and encouraging 
and inspiring our next generation of leaders,” President 
Obama said in a White House statement.  
 Throughout his career, Laurencin has earned national  
and international prominence as an orthopaedic surgeon  
and chemical engineering expert. He holds the Health Center’s 
Van Dusen Endowed Chair in Academic Medicine and is a 
professor in the Department of Orthopaedic Surgery. He also 
holds an appointment in the UConn School of Engineering 
as a professor of chemical, materials and biomolecular 
engineering. He is a fellow of the American Surgical 
Association and the American Academy of Orthopaedic 
Surgeons and was named one of the 100 engineers of the 
modern era by the American Institute of Chemical Engineers. 
 Laurencin joined UConn in 2008 from the University 
of Virginia where he was the Lillian T. Pratt Distinguished 
Professor and chair of the Department of Orthopaedic  
Surgery, the orthopaedic surgeon-in-chief at the University  
of Virginia Health System and a university professor, one  
of the university’s most prestigious titles. n 
Physician-Researcher Honored 
Zihai Li, M.D., Ph.D., a prominent physician-researcher and leader in the field of immunotherapy, was 
recently inducted into the American 
Society for Clinical Investigation, one of 
the nation’s oldest and most respected 
medical honor societies. 
 Li’s research team has made seminal 
contributions to understanding the 
immunological properties of heat shock proteins (HSPs) in 
cancer immunotherapy and immune tolerance. His work has 
broad implications in understanding how the immune system 
operates physiologically and how it might be harnessed for the 
prevention and treatment of human diseases. n
Kastner 
Receives AMA Leadership Award
Theodore A. Kastner, ’81, M.D., M.S., founder and president of Developmental Disabilities Health Alliance (DDHA), a New Jersey health care organization exclusively 
for individuals with developmental disabilities, has been 
named a recipient of the American Medical Association’s 2008 
Leadership Award. 
 Kastner was among 56 individuals nationwide honored 
by the AMA Foundation at its annual Excellence in Medicine 
Awards ceremony. Recipients of the award are recognized for 
demonstrating outstanding non-clinical leadership skills in 
advocacy, community service and education. 
 Throughout his career, Kastner has focused on a chronically 
underserved population: people with developmental 
disabilities. DDHA began as a single office in 1997 serving 200 
patients; today, it has six offices across New Jersey providing 
comprehensive health care services to more than 3,000 patients 
and health care management to 3,400 patients. n
Honors
Improving Access to Colonoscopies
Earlier this year, a statewide effort led by the UConn Health Center’s Colon Cancer Prevention Program made colonoscopies available to uninsured and underinsured Connecticut residents. The initiative provided colonoscopies to nearly 300 patients at no 
cost to them, nearly 50 of them done by Joseph C. Anderson, M.D., at the UConn Health Center. 
 “The colonoscopy is a major prevention tool, but not everyone has access,” says Anderson, 
the clinical director of the colon cancer prevention program and medical director for the 
Connecticut project. “The more people we can screen, the more people we can help. Polyps in 
the colon will become cancerous whether people have insurance or not.” 
 Unfortunately for those without insurance, the cost of the test, which can detect early signs 
of cancer, generally places it out of their reach.  
 Using a grant of $950,000 from the state Department of Public Health, the Health Center 
formed a partnership with federally funded community health centers and endoscopists 
around the state to identify patients between the ages of 50 and 65 and provide them with 
colonoscopies. The program provided follow-up services to participants. 
 “The goal is to promote, improve and optimize the appropriate use of high quality  
colorectal cancer screening and follow-up services, and eliminate or decrease racial, ethnic  
and socioeconomic disparities in access to these screenings,” says Jennifer Granger, chief 
operating officer of the Community Health Center Association of Connecticut.  
 Colon cancer is the second most common cancer and the third leading cause of cancer 
deaths in the nation. n
A$3.8 million gift from Carole and Ray Neag, two of the university’s 
most generous supporters, will 
help the Health Center upgrade 
its diagnostic, planning and 
treatment services.  
 The first installment, a new 
computerized tomography (CT) 
scanner offering unprecedented 
precision, speed and patient 
comfort, arrived this spring.  
The new scanner uses “dual-
source energy” technology, in 
which two sources of radiation 
are used to acquire information 
and create a complex 3D image 
of a patient’s anatomy. The 
technology gives physicians and 
researchers sophisticated images 
not previously available. 
 The Neags’ gift also provides 
for a high-dose radiation system 
and a CT simulator which, 
together with the scanner and the 
TomoTherapy cancer treatment 
system (provided by a previous 
gift from the Neags), greatly 
enhances research, education and 
treatment at the Health Center. 
 “Its functionality for 
cardiology alone will be leaps 
and bounds beyond our existing 
capabilities,” says Bruce Liang, 
M.D., director of the Pat and Jim 
Calhoun Cardiology Center.  
 Advantages of the new 
scanner include clearer images, a 
90 percent reduction in scanning 
times and selective presentation 
of a scanned image. The CT 
simulator will enhance treatment 
planning, and the high dose 
rate brachytherapy will treat a 
variety of cancers at the Neag 
Comprehensive Cancer Center.  
 “Carole and I feel strongly 
about the state and its university, 
and believe the state’s flagship 
research university should have 
the very best if at all possible,” 
says Ray Neag. n
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Director of New England 
Musculoskeletal Institute  
Is Named Fellow of AIMBE
T he American Institute for Medical and Biological Engineering has inducted Jay R. Lieberman, M.D., an internationally recognized 
joint replacement expert and director of the Health 
Center’s New England Musculoskeletal Institute, 
into its College of Fellows. 
 Lieberman, professor and chairman of the 
Department of Orthopaedic Surgery and a member of 
both the prestigious Hip Society and Knee Society, was 
nominated for “significant and sustained contributions 
to understanding the biology of arthroplasty implants, 
and for innovative strategies for bone regeneration 
using gene therapy and materials science,” according 
              to the AIMBE. 
